|
ERLIN1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.20590212762772E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
4.796300E-04 |
| Normal-vs-Stage3 |
5.834900E-04 |
| Normal-vs-Stage4 |
4.251000E-01 |
| Stage1-vs-Stage2 |
2.657200E-01 |
| Stage1-vs-Stage3 |
3.442000E-02 |
| Stage1-vs-Stage4 |
9.183500E-02 |
| Stage2-vs-Stage3 |
5.544200E-01 |
| Stage2-vs-Stage4 |
2.009000E-01 |
| Stage3-vs-Stage4 |
3.257200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.59428026336172E-13 |
| Normal-vs-AfricanAmerican |
1.10910003403575E-09 |
| Normal-vs-Asian |
4.308000E-01 |
| Caucasian-vs-AfricanAmerican |
5.461400E-01 |
| Caucasian-vs-Asian |
3.665000E-01 |
| AfricanAmerican-vs-Asian |
2.209600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
5.015800E-04 |
| Male-vs-Female |
4.00210000000012E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.4371999973738E-08 |
| Normal-vs-Extreme_Weight |
1.62436730732907E-12 |
| Normal-vs-Obese |
1.86719995021178E-09 |
| Normal-vs-Extreme_Obese |
7.8733999986369E-08 |
| Normal_Weight-vs-Extreme_Weight |
3.394200E-02 |
| Normal_Weight-vs-Obese |
7.131800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.067800E-01 |
| Extreme_Weight-vs-Obese |
2.378400E-03 |
| Extreme_Weight-vs-Extreme_Obese |
4.835600E-01 |
| Obese-vs-Extreme_Obese |
3.447400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.720000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.71139793845055E-11 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
3.02479996605598E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.073430E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.472300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.612300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.022400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.396200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.224800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
3.06654701631714E-12 |
| Normal-VS-KIRP CIMP |
4.758000E-02 |
| Normal-VS-Unclassified PRCC |
2.30670000000988E-06 |
| Type1 PRCC-VS-Type2 PRCC |
3.062200E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.379900E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
3.638300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.261240E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.869800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.88930000000198E-06 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.09288142372088E-12 |
| Normal-vs-N1 |
2.388000E-01 |
| Normal-vs-N2 |
9.354800E-01 |
| N0-vs-N1 |
1.400610E-03 |
| N0-vs-N2 |
2.077000E-01 |
| N1-vs-N2 |
5.715000E-01 |
|
|
